E0 ConsensusPreliminaryPEM unclearSystematic-ReviewPeer-reviewedReviewed
Brainstem Abnormalities in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Scoping Review and Evaluation of Magnetic Resonance Imaging Findings.
Nelson, Todd, Zhang, Lan-Xin, Guo, Hui et al. · Frontiers in neurology · 2021 · DOI
Quick Summary
This review examined brain imaging studies to understand how ME/CFS affects the brainstem, which is the part of the brain that controls vital functions like heart rate, breathing, and sleep. Researchers found that people with ME/CFS often show changes in the brain's structure and how different brain regions communicate with each other. These findings suggest that problems in the brainstem might explain many ME/CFS symptoms, though more research is needed to fully understand the connections.
Why It Matters
This review consolidates emerging evidence that brainstem dysfunction may be a key biological feature of ME/CFS, helping legitimize the search for measurable brain abnormalities in this condition. Understanding brainstem involvement could guide future diagnostic approaches and targeted therapeutic interventions, improving clinical management and validating the biomedical nature of ME/CFS.
Observed Findings
- MRI studies frequently reported structural changes in brainstem white and gray matter in ME/CFS patients
- Abnormal functional connectivity was detected within the brainstem and between the brainstem and other brain regions
- Proposed mechanisms include astrocyte dysfunction, cerebral perfusion impairment, impaired nerve conduction, and neuroinflammation
- Brainstem abnormalities may partially explain the heterogeneous symptom presentations across ME/CFS patients
Inferred Conclusions
- The brainstem plays an important role in ME/CFS pathophysiology based on convergent MRI evidence
- Multiple potential mechanisms (inflammatory, vascular, and neuronal) may underlie brainstem dysfunction in this condition
- Brainstem-focused research could advance understanding of ME/CFS heterogeneity and inform future diagnostic and therapeutic approaches
Remaining Questions
- Are brainstem abnormalities present in all ME/CFS patients or only specific subgroups, and do they correlate with symptom severity or type?
- Which proposed mechanisms (neuroinflammation, perfusion impairment, astrocyte dysfunction, etc.) are primary versus secondary, and how do they interact?
- Can brainstem imaging findings serve as reliable biomarkers for ME/CFS diagnosis or for monitoring treatment response?
What This Study Does Not Prove
This review does not prove that brainstem abnormalities cause ME/CFS symptoms—it documents associations found on imaging studies. The findings are correlational and do not establish definitive causation or identify which abnormalities are primary versus secondary. Individual study limitations and the heterogeneous nature of findings mean this review cannot yet provide a unified explanation for all ME/CFS pathophysiology.
Tags
Symptom:Post-Exertional MalaiseCognitive DysfunctionFatigueOrthostatic IntolerancePainTemperature Dysregulation
Biomarker:Neuroimaging
Method Flag:Weak Case DefinitionExploratory Only
Metadata
- DOI
- 10.3389/fneur.2021.769511
- PMID
- 34975729
- Review status
- Editor reviewed
- Evidence level
- Established evidence from major reviews, guidelines, or evidence maps
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.